
International Oncology Experts Meet In Kenya To Address Regional Cancer Needs
"The ACS Global Academy Regional Meetings aim to provide a productive and dedicated space for providers to learn from one another, engage in discourse, and reach consensus on regional needs," said Anu Agrawal, MD, Vice President, Global Cancer Support, American Cancer Society . "Continuing the collaboration with ACC and NCCN on the development and update of NCCN Harmonized GuidelinesTM provides an essential framework to better understand localized needs and priorities, a key part of this regional meeting in Nairobi."
NCCN Guidelines® contain the latest evidence-based, expert consensus-driven recommendations for cancer prevention, screening, treatment, and supportive care. They are the most thorough and frequently updated clinical practice guidelines available in any area of medicine. Approximately half of the two million registered users are from outside the United States, across 190 different countries. The NCCN Global Program oversees adapting and translating the original recommendations to be more accessible for care providers worldwide.
During the meeting, the following NCCN Harmonized GuidelinesTM for Sub-Saharan will be updated:
-
Anal Carcinoma
Biliary Tract Cancers
Bladder Cancer
Cervical Cancer
Colon Cancer
Colorectal Cancer Screening
Gestational Trophoblastic Neoplasia (GTN)
Hepatocellular Carcinoma
Kidney Cancer
Ovarian Cancer
Penile Cancer
Rectal Cancer
Testicular Cancer
Uterine Neoplasms
Vulvar Cancer
"We have been working in collaboration with experts from ACC across the Sub-Saharan Africa area and ACS for many years to share guidelines that are both aspirational and pragmatic," said Crystal S. Denlinger, MD, Chief Executive Officer, NCCN . "In that time, we have seen improved capacity in cancer-related resources and care, but we have also seen increased cancer rates for the people who live in this region. Our commitment to collaborate with leading experts in the region to maintain and update treatment recommendations, based on the latest research and local circumstances, is more important than ever."
Dr. Denlinger is representing NCCN at the meeting, along with Nadeem R. Abu-Rustum, MD , Memorial Sloan Kettering Cancer Center, Chair, NCCN Guidelines Panel for Cervical/Uterine Cancers; Al Benson, MD , Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chair, NCCN Guidelines Panels for Colon/Rectal/Anal Cancers and Hepatobiliary Cancers; Thomas Flaig, MD , University of Colorado Cancer Center, Chair, NCCN Guidelines Panel for Bladder/Penile Cancers; Lisa Gurski, PhD , Manager, Licensed Clinical Content, NCCN; Vaishnavi Sambandam, PhD , Oncology Scientist/Medical Writer, NCCN; and Katy Winckworth-Prejsnar, MPH , Director, Global Program, NCCN.
Visit NCCN/global to learn more about free resources for improving cancer treatment around the world.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN ® ) is marking 30 years as a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to defining and advancing quality, effective, equitable, and accessible cancer care and prevention so all people can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ® ) provide transparent, evidence-based, expert consensus-driven recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation ®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN for more information.
Media Contact:
Rachel Darwin
267-622-6624
[email protected]
SOURCE National Comprehensive Cancer Network

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- B2PRIME Announces B2MEET - Private Forums For Top-Tier Market Insights
- PU Prime X AFA Launch Official Football Giveaway
- Klein Funding And Bybit Partner To Launch A New Era Of Crypto Prop Trading
- SBI VEN CAPITAL INVESTS €1 MILLION IN COLOSSUS DIGITAL's BRIDGE ROUND
- Visby Management Reiterates Superior Offer To LCL Resources
- Nibiru Launches”Block Party” Aura Program To Reward Real Defi Activity
Comments
No comment